172 related articles for article (PubMed ID: 16296946)
21. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacogenetics in fluoropyrimidine chemotherapy].
Ichikawa W; Sasaki Y
Gan To Kagaku Ryoho; 2008 Feb; 35(2):178-81. PubMed ID: 18281752
[TBL] [Abstract][Full Text] [Related]
23. Somatic pharmacogenomics in cancer.
Ikediobi ON
Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
[TBL] [Abstract][Full Text] [Related]
24. Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?
Marcuello E; Altés A; Menoyo A; Rio ED; Baiget M
Cancer Chemother Pharmacol; 2006 Jun; 57(6):835-40. PubMed ID: 16187112
[TBL] [Abstract][Full Text] [Related]
25. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
Lee W; Lockhart AC; Kim RB; Rothenberg ML
Oncologist; 2005 Feb; 10(2):104-11. PubMed ID: 15709212
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy of colorectal cancer: history and new themes.
Bertino JR
Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-3-S18-7. PubMed ID: 9420015
[TBL] [Abstract][Full Text] [Related]
27. [5-fluorouracil and dihydropyrimidine dehydrogenase].
Kubota T
Gan To Kagaku Ryoho; 2001 Apr; 28(4):433-9. PubMed ID: 11329775
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutations in the DPD gene, and DPD inhibitory fluoropyrimidines.
Omura K
Int J Clin Oncol; 2003 Jun; 8(3):132-8. PubMed ID: 12851836
[TBL] [Abstract][Full Text] [Related]
29. [Recent advances in pharmacogenomics in oncology].
Robert J; Bonnet J
Bull Cancer; 2004 Jan; 91(1):19-28. PubMed ID: 14975802
[TBL] [Abstract][Full Text] [Related]
30. Individualized chemotherapy treatment for breast cancer: is it necessary? Is it feasible?
Pusztai L; Rouzier R; Wagner P; Symmans WF
Drug Resist Updat; 2004 Dec; 7(6):325-31. PubMed ID: 15790543
[TBL] [Abstract][Full Text] [Related]
31. Evolution of pharmacogenomics.
Somogy A
Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetics in gastrointestinal tumors.
Stöhlmacher J
Onkologie; 2005 Aug; 28(8-9):435-40. PubMed ID: 16160407
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetic testing to predict serious toxicity from 5-fluorouracil (5-FU) for patients administered 5-FU-based chemotherapy for cancer.
Technol Eval Cent Assess Program Exec Summ; 2010 Aug; 24(13):1-3. PubMed ID: 21114065
[No Abstract] [Full Text] [Related]
34. Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.
Rich TA; Shepard RC; Mosley ST
J Clin Oncol; 2004 Jun; 22(11):2214-32. PubMed ID: 15169811
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.
Boyer J; Allen WL; McLean EG; Wilson PM; McCulla A; Moore S; Longley DB; Caldas C; Johnston PG
Cancer Res; 2006 Mar; 66(5):2765-77. PubMed ID: 16510598
[TBL] [Abstract][Full Text] [Related]
36. Hypertension pharmacogenomics: current status and future directions.
Johnson JA; Turner ST
Curr Opin Mol Ther; 2005 Jun; 7(3):218-25. PubMed ID: 15977418
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in the pharmacogenetics of cancer chemotherapy.
Watters JW; McLeod HL
Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications.
Abdel-Hamid IA; Andersson KE
Pharmacogenomics; 2009 Oct; 10(10):1625-44. PubMed ID: 19842936
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs.
Ganapathi RN; Ganapathi MK
Urol Oncol; 2014 Jan; 32(1):1-4. PubMed ID: 24360658
[No Abstract] [Full Text] [Related]
40. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
